Indian Entrepreneurs 2026.
India's entrepreneurial landscape in 2026 is being shaped by leaders who are looking beyond conventional business models to solve deeper, often overlooked challenges. Against this backdrop, these entrepreneurs stand out for the distinct challenges they have chosen to address and the approaches they have taken to create meaningful change in their respective fields. Their journeys offer a closer look at the ideas, experiences and ambitions shaping India's entrepreneurial landscape in 2026.
Akshi Khandelwal founded Butterfly Ayurveda in 2014 to close a gap she saw everywhere: despite Ayurveda's Indian roots, few understood its everyday relevance. A Yale alumna with an MA in International Development Economics, she also trained extensively in Shaolin Kungfu, Tai Chi, and Qi Gong under Shi Yan Xiang, a 34th Generation Shaolin Temple Warrior Monk; a fusion of academic rigor and physical discipline that shaped her holistic approach to wellness.
Since 2013, her R&D-driven approach has produced over 52 in-house Ayurvedic formulations, from teas to supplements, alongside a GMP-certified manufacturing unit. In 2018, she expanded into food with Butterfly Ayurveda Bakery.
Building on this momentum, she founded Café Swasthya,which has now grown to four outlets, serving 100% natural, preservative-free food in recipes backed by research to balance the body's Tridosha - tackling what she calls an overlooked crisis: metabolic dysfunction and its cascading health effects.
Akshi was also selected for the Fortune Women's Mentoring Partnership in 2019, recognized among Republic World's "India's Changemakers of 2025, and won Women Listed's Celebrating Excellence Award in 2025.
True to her brand's name, inspired by the butterfly's metamorphosis, Akshi continues to build on that vision, with new outlets and formulations in the pipeline.
Ashissh Raichura is the Founder and CEO of Scanbo Technologies, a healthcare AI company building point-of-care diagnostic technology deployed across hundreds of clinical settings in India and preparing for global expansion. Trained as an electronics engineer with two PhDs in Artificial Intelligence and Cloud Computing, he has spent over a decade building AI systems that support clinicians rather than replace them.
Under his leadership, Scanbo has launched CDSCO-approved products including the Scanbo D8 multi-parameter diagnostic device and HridayTaal, a cardiac AI agent that has completed over one million AI analyses in real clinical environments. The company operates its own manufacturing facility built to global standards under a Make in India strategy, holds international certifications including ISO 13485, HIPAA, and SOC2, and is now pursuing US FDA clearance.
In 2017, in a New Delhi pharmacy, Kinshuk Kocher watched a newly diagnosed diabetic patient nod along to a pharmacist's instructions, already sensing the schedule wouldn't be followed by week's weekend. That quiet observation became the founding insight behind Caredose, a medication-adherence platform built to solve one of healthcare's most underestimated problems: not diagnosis, not drugs, but whether patients actually take what they're prescribed.
Kocher's path to that pharmacy counter was anything but conventional. He began his career at McKinsey, before completing an MBA at the University of Oxford, where his view of healthcare shifted from operational detail to systemic design. It was the years that followed, building Caredose from the ground up in India, that shaped his sharpest insight: the patient behaviour problem looks the same everywhere, only the context changes.
Under his leadership, Caredose went on to manage over one million medicine doses across India, and formed partnerships with WHO, USAID, the Gates Foundation, Apollo Pharmacy, and Max Hospitals, culminating in a successful exit.
What sets Kocher apart is his refusal to treat medication adherence as a side feature of healthcare. He built an entire company around a problem most of the industry still treats as an afterthought, and did it inside one of the world's most resource-constrained, high-improvisation health systems.
Today, Kocher serves as Director of Investment Operations and Special Projects at Cedars-Sinai Technology Ventures in Los Angeles, where he evaluates and supports health-tech startups, carrying the same operator's instincts he built in New Delhi into one of America's leading health-tech investment arms.
His journey and perspective have been featured in Outlook Business, NewsX, The Hindu, and other national and international publications.
Kinshuk Kocher didn't wait for healthcare's next breakthrough. He went looking for the problem no one else wanted to solve first.
For over three decades, Sujata Deshmukh has helped leaders build institutions that endure. Working at the intersection of leadership, culture, and organization development, she has partnered with more than 500 organizations across 12 countries, guiding founder-led startups, family businesses, multinational corporations, and public institutions through growth, transformation, and succession.
Recognizing that lasting organizational change begins with leadership, Sujata founded Tutul Consulting to help organizations align purpose, culture, and leadership with long-term performance. In just seven years, the firm has partnered with over 100 clients, supporting leadership teams in building resilient, purpose-driven institutions.
Known for combining systems thinking, thoughtful inquiry, and practical collaboration, Sujata helps leaders navigate complex organizational challenges, uncover hidden patterns, and make wiser decisions. The trust she builds is reflected in client relationships that have endured for decades.
Beyond consulting, she serves as an Advisor and Independent Director, has been a member of the National Executive Board of the National HRD Network, teaches at business schools, contributes to the healthcare social sector, and is a sought-after speaker, including at TEDx.
Driven by the belief that institutions outlast individuals, Sujata continues to help leaders create organizations that inspire people today and remain meaningful for generations to come.
A Chartered and Management Accountant with over 33 years of global experience, Soumik Bandyopadhyay has held roles as CFO, CEO, Director, MD, and Advisor across companies including SRF Limited, Amway India Enterprises, Modicare Limited, ALJ Retail Company, ATS Infrastructure, Samtel Group, and MALJ Company, spanning diverse industries of engineering, FMCG, auto and industrial equipment distribution, electronics manufacturing, real estate and family office over diverse geographies of India and abroad. That breadth gave him a rare vantage point into how family businesses truly function, and falter, across generations.
Today, as Founder of SBAPL, Bandyopadhyay applies that experience to one of Indian business's least formalised challenges: protecting family wealth and legacy with institutional rigour. Specialising in risk management for UHNW and HNW families, he designs sophisticated mitigation frameworks, leveraging his global expertise and national and international network of legal and tax professionals to maximise financial and risk efficiency. His work extends to crafting bespoke strategies aligned to each family's goals and risk appetite, in the areas of asset protection, risk management, succession planning, family governance, legacy and self-sustaining philanthropic initiatives that ensure smooth generational transitions.
Beyond advisory, Bandyopadhyay is a sought-after voice at business schools and industry events, coaching the next generation of family business leaders, reinforcing his reputation as a trusted steward of legacy and long-term wealth.
Together, their stories reflect the breadth of entrepreneurship and leadership emerging from India in 2026. Whether through healthcare technology, traditional wellness, patient-focused innovation or stronger organisational systems, their work demonstrates how entrepreneurial impact can extend beyond business growth to influence industries, institutions and the people they serve.
